SEATTLE, July 30, 2021, (MEDGADGET) — Global Peptic Ulcer Drugs Market Analysis
Overview
Open sores on the inner lining of the stomach and the upper part of the small intestine are known as peptic ulcers. Peptic ulcers are divided into two types: gastric ulcers and duodenal ulcers. The loss of the thick layer of mucus that protects the stomach from intestinal juices causes PUD (peptic ulcer disease).
By the end of 2027, the worldwide peptic ulcer drugs market is expected to be worth US$ 45,951.2 million.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/3246
Drivers
The rising prevalence of peptic ulcers is expected to propel growth of the global peptic ulcer drugs market during the forecast period. As per the report, ‘A36 The Global Prevalence of Peptic Ulcer Disease and Its Complications at the Turn of the Twenty-First Century: A Systematic Review,’ Spain had the largest annual incidence of all PUD of 141.8 cases per 100,000 people.
Furthermore, changes in lifestyle, such as stress, diet, and a high prevalence of smoking, are projected to drive growth of the global peptic ulcer drugs market over the forecast period. According to the World Health Organization, 1.337 billion people globally smoked cigarettes in 2018.
In terms of value, North America dominated the global peptic ulcer drugs market in 2018, contributing about 41.4 percent of the overall market share, led by Europe.
“Limited Time Offer”
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3246
Restraints
Extended use of peptic ulcer medications including proton pump inhibitors and antibiotics will improve the risk of hip bone fracturing by reducing the capacity to digest calcium and iron. Due to a reduction of normal intestinal flora, there is a chance of opportunistic infections with S. pneumonia and C. defficile. The global peptic ulcer drugs market is estimated to be hampered as a result of this situation.
Furthermore, the growth of the global peptic ulcer drugs market is expected to be hampered by the widespread availability of generic medications and low patient adherence to treatment in certain countries.
Opportunities
To increase their market share, major competitors should concentrate on customized care and management of PUD patients. Researchers from the Institute of Medical Microbiology in Switzerland hypothesized in a report published in the Journal of Clinical Medicine in July 2019 that next-generation sequencing technologies could help with rapid monitoring of virulence determinants in H. pylori, which could help with targeted care and control of patients with PUD.
High doses of NSAIDs (non-steroidal anti-inflammatory drugs) have also been linked to an increased risk of chronic PUD. Thus, market players may concentrate their research and development efforts on H. pylori eradication therapy, which has the potential to reduce the risk of persistent PUD in NSAID users.
The global peptic ulcer drugs market’s proton pump inhibitors segment was worth US$ 24,799.4 million in 2018, which is projected to grow at a CAGR of 2.8 percent to US$ 31,895.7 million by 2027.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/peptic-ulcer-drugs-market-2615
Market Trends
The use of artificial intelligence (AI) in the management of peptic ulcers is a significant development in the global peptic ulcer drugs market. Inspirata, a US-based cancer informatics and digital pathology provider, collaborated with DeePathology on AI-based Helicobacter Pylori pathology research in December 2019.
The effectiveness of potassium-competitive acid blockers in combination therapy for the treatment of PUD is being studied by major companies. Phathom Pharmaceuticals launched a pivotal phase III trial in December 2019 to evaluate the effectiveness of Vonoprazan in combination with Amoxicillin and Vonoprazan in combination with Amoxicillin and Clarithromycin for the effective eradication of H. pylori infection.
Regulations
The U.S. FDA is currently reviewing the risk of Clostridium difficile–associated diarrhea (CDAD) in users of histamine H2 receptor blockers. H2 receptor blockers are used for the treatment of gastro esophageal reflux disease (GERD), stomach and small intestine ulcers, and heartburn.
Competitive Landscape
Key companies contributing in the global peptic ulcer drugs market are RedHill Biopharma, Novitium Pharma LLC, Takeda Pharmaceutical Co., Ltd., Abbott Laboratories, Eisai Co. Ltd., Daewoong Pharmaceutical Co., Ltd., GlaxoSmithKline plc., Yuhan Corporation, AstraZeneca plc., Pfizer Inc., Boehringer Ingelheim GmbH, Cadila Healthcare Ltd.,
Key Developments
To broaden their product range, key market players are focusing on product acceptance and launch. Talicia, a treatment for Helicobacter pylori (H. pylori) infection in adults, regardless of ulcer status, was approved by the US FDA in November 2019.
In October 2019, Novitium Pharma LLC made a recall of ranitidine hydrochloride capsules in the U.S. due to elevated levels of NDMA (N-Nitrosodimethylamine), a suspected human carcinogen, above the FDA’s limits.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippets, By Disease Indication
- Market Snippets, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
- Market Dynamics
- Global Peptic Ulcer Drugs Market, By Product Type, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Proton Pump Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Potassium-Competitive Acid Blocker (P-CAB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Antacids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- H2- Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Ulcer Protective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Peptic Ulcer Drugs Market, By Disease Indication, 2019 – 2027, (US$ Mn)
- Gastitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Gastric Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Duodenal Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Gastroesophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Gastitis
- Global Peptic Ulcer Drugs Market, By Distribution Channel, 2019 – 2027, (US$ Mn)
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Private Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Drug Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- E-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Hospitals Pharmacies
- Global Peptic Ulcer Drugs Market, By Region, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Other Related Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837